LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.00033333
 30.90 27.76 2636 2032 1.2970 1.0858
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
 30.90 27.76 2353 2032 1.1578 1.0479
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
 30.90 27.76 2399 2032 1.1804 1.0543
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
 32.60 27.76 90 2235 0.0403 0.2042
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
 32.60 27.76 2860 2235 1.2792 1.0793
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
 32.60 27.76 2643 2235 1.1821 1.0535
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
 32.60 27.76 2683 2235 1.2000 1.0584
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
 34.30 27.76 261 2449 0.1065 0.4144
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
 34.30 27.76 3175 2449 1.2960 1.0819
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
 34.30 27.76 2843 2449 1.1605 1.0466
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
 34.30 27.76 2890 2449 1.1797 1.0518
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
 36.01 27.76 300 2662 0.1127 0.4355
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
 36.01 27.76 3450 2662 1.2956 1.0802
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
 36.01 27.76 3045 2662 1.1435 1.0411
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
 36.01 27.76 3083 2662 1.1577 1.0450
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
 37.71 27.76 385 2877 0.1338 0.4810
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
 37.71 27.76 3715 2877 1.2910 1.0778
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
 37.71 27.76 3179 2877 1.1047 1.0300
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
 37.71 27.76 3214 2877 1.1169 1.0333
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
 39.41 27.76 421 3105 0.1356 0.4911
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
 39.41 27.76 3970 3105 1.2783 1.0735
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
 39.41 27.76 3466 3105 1.1160 1.0325
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
 39.41 27.76 3499 3105 1.1267 1.0354
MN20160318_Q01
K07
MCF 10A-H2B-mCherry Trametinib
0.00033333
 41.11 27.76 409 3331 0.1228 0.4762
MN20160318_Q01
I12
MCF 10A-H2B-mCherry Trametinib
0.00033333
 41.11 27.76 4173 3331 1.2526 1.0663
MN20160318_Q01
I12